Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Thousand Oaks, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Atara Biotherapeutics, Inc. has filed 1,129 SEC EDGAR filings since 10 Apr 2014

SEC filing history

Showing 751-775 of 1,000 matching filings.

Per page
25
Current page
31
4

FORM 4 SUBMISSION

Filing date
17 Nov 2017
Reporting date
15 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Nov 2017
Reporting date
13 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36548

8-K Q3 EARNINGS RELEASE

Filing date
09 Nov 2017
Reporting date
09 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Oct 2017
Reporting date
26 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Oct 2017
Reporting date
16 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
12 Oct 2017
Reporting date
11 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Sep 2017
Reporting date
19 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Sep 2017
Reporting date
15 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Sep 2017
Reporting date
06 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Aug 2017
Reporting date
22 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Aug 2017
Reporting date
15 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Aug 2017
Reporting date
15 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Aug 2017
Reporting date
15 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Aug 2017
Reporting date
15 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Aug 2017
Reporting date
15 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Aug 2017
Reporting date
15 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
17 Aug 2017
Reporting date
15 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Aug 2017
Reporting date
10 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-219763

S-8 - 2017 EVERGREEN AND NASDAQ

Filing date
07 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36548

8-K - Q2 2017

Filing date
07 Aug 2017
Reporting date
07 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Jul 2017
Reporting date
24 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 Jul 2017
Reporting date
17 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Jun 2017
Reporting date
15 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .